U.S. drug maker Eli Lilly & Co. is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by ...
Woman's World on MSN
New weight loss drug beats Ozempic and eases joint pain with 'insane' results, doctors say
Brace yourselves, Ozempic and Zepound. Eli Lilly just released a jaw-dropping sneak peek from the final phases of testing for ...
7h
Federal judges consolidate GLP-1 vision loss lawsuits, sends cases to federal judge in Pennsylvania
Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...
The investment narrative surrounding Novo Nordisk is undergoing a significant shift. After years of soaring expectations fueled by its obesity and diabetes t ...
Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major ...
Despite the widespread popularity of new weight-loss medications, research suggests a non-drug alternative is significantly ...
Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback